TARPLIN, DOWNS & YOUNG, LLC

Lobbying for FOUNDATION MEDICINE · Molecular insight company, connects physicians & patients to the latest cancer treatment

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $80,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening

Medicare/Medicaid

companion diagnostics, payment issues

Trade (domestic/foreign)

supply chain

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.